Addus HomeCare Corporatio... (ADUS)
97.38
-0.42 (-0.43%)
At close: Mar 28, 2025, 3:59 PM
96.02
-1.40%
After-hours: Mar 28, 2025, 06:25 PM EDT
Addus HomeCare Corporation Revenue Breakdown
| Quarter | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Sep 30, 2012 | Jun 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospice Revenue | 57.31M | 55.86M | 372.64M | 53.12M | 19.33M | 18.45M | 183.37M | 18.14M | 17.25M | 16.33M | 22.5M | 24.13M | 25.54M | 27.57M | 28.05M | 28.38M | 27.24M | 31.84M | 32.66M | 34.91M | 23.02M | 17.81M | 128.09M | 125.06M | 11.43M | 11.63M |
| Hospice Revenue Growth | +2.59% | -85.01% | +601.49% | +174.78% | +4.77% | -89.94% | +910.89% | +5.18% | +5.62% | -27.41% | -6.76% | -5.51% | -7.40% | -1.68% | -1.18% | +4.17% | -14.43% | -2.51% | -6.46% | +51.66% | +29.23% | -86.09% | +2.42% | +994.66% | -1.72% | n/a |
| Personal Care Revenue | 215.43M | 208M | 23.85M | 201.88M | 198.31M | 21.89M | 9.16M | 21M | 21.13M | 21.39M | 7.72M | 7.96M | 4.72M | 4.34M | 4.04M | 4.08M | 3.78M | 4.34M | 4.4M | 4.37M | 3M | 2.7M | 2.42M | 1.52M | n/a | n/a |
| Personal Care Revenue Growth | +3.57% | +772.09% | -88.19% | +1.80% | +806.16% | +139.00% | -56.39% | -0.62% | -1.21% | +177.01% | -2.99% | +68.71% | +8.69% | +7.48% | -1.15% | +7.98% | -12.81% | -1.36% | +0.76% | +45.48% | +11.31% | +11.36% | +58.96% | n/a | n/a | n/a |
| Home Health Revenue | 17.05M | 16.88M | 116.25M | 15.72M | 8.09M | 9.12M | 18.79M | 8.38M | 9.07M | 7.51M | 16.74M | 15.87M | 14.69M | 14.11M | 9.22M | 10.98M | 11.44M | 11.01M | 11.56M | 10.87M | 8.44M | 7.92M | 7.12M | 4.65M | n/a | n/a |
| Home Health Revenue Growth | +0.98% | -85.48% | +639.60% | +94.22% | -11.22% | -51.48% | +124.35% | -7.66% | +20.79% | -55.14% | +5.49% | +7.99% | +4.11% | +53.13% | -16.05% | -4.05% | +3.94% | -4.78% | +6.33% | +28.88% | +6.57% | +11.26% | +53.07% | n/a | n/a | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| New York Revenue | 40.7M | 39.2M | 42M |
| New York Revenue Growth | +3.83% | -6.67% | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 71.36M | 62.8M | 63.58M | 61.06M | 60.27M | 60.27M | 57.4M | 56.36M | 54.47M | 54.23M | 55.09M | 53.15M | 49.54M | 46.28M | 48.17M | 45.43M | 44.21M | 40.81M | 42.1M | 42.29M | 38.14M | 35.95M | 30.22M | 29.26M | 28.94M | 28.22M | 26.41M | 21.46M | 19.66M | 19.36M | 19.01M | 20.91M | 19.26M | 23.21M | 19.56M | 22.19M | 17.97M | 18.04M | 17.42M | 17.15M |
| Selling, General, and Administrative Revenue Growth | +13.62% | -1.21% | +4.12% | +1.32% | -0.01% | +5.01% | +1.84% | +3.48% | +0.44% | -1.57% | +3.66% | +7.30% | +7.04% | -3.93% | +6.05% | +2.75% | +8.34% | -3.07% | -0.45% | +10.87% | +6.09% | +18.95% | +3.30% | +1.10% | +2.55% | +6.85% | +23.06% | +9.14% | +1.57% | +1.86% | -9.08% | +8.54% | -17.01% | +18.66% | -11.86% | +23.50% | -0.42% | +3.55% | +1.57% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |